Tags : Congo

Pharma

Congo Approves Experimental Ebola Treatments by Gilead, Mapp, Toyama Chemical

Shots: Congo approves experimental Ebola treatments including Remdesivir by Gilead Sciences; ZMapp by Mapp Pharmaceutical; Favipiravir by Toyama and Regn3450, Regn3471, Regn3479 by Regeneron Pharmaceuticals Health authorities has approved these experimental treatments, as the Ebola epidemic continues to spread   Total number of death are 59 and confirmed cases to 75 since last month, with […]Read More